Technical Analysis for MXC - MGC Pharmaceuticals Limited

Grade Last Price % Change Price Change
C 21.00 -4.55% -1.00
MXC closed down 4.55 percent on Monday, March 18, 2024, on 16 percent of normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
20 DMA Support Bullish -4.55%
50 DMA Support Bullish -4.55%
Boomer Buy Setup Bullish Swing Setup -4.55%
Bollinger Band Squeeze Range Contraction -4.55%
Stochastic Reached Overbought Strength -4.55%

   Recent Intraday Alerts

Alert Time
Fell Below 50 DMA about 23 hours ago
Fell Below 20 DMA about 23 hours ago
Fell Below 10 DMA about 23 hours ago
Down 5% about 24 hours ago
Down 3% about 24 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MGC Pharmaceuticals Limited Description

MGC Pharmaceuticals Limited, together with its subsidiaries, produces and supplies phytocannabinoid derived medicines in Australia and Slovenia. The company's products under development include CannEpil, which is in Phase IIb clinical trial for the treatment in children and adolescents with refectory epilepsy; CogniCann that is in Phase II clinical trial to treat dementia and Alzheimer's diseases; and ArtemiC, which is in Phase II clinical trial for the treatment COVID-19. It has strategic collaborative partnership agreements Epilepsy Action Australia, Royal Melbourne Institute of Technology, the University of Notre Dame in Western Australia, as well as the National Institute of Biology & University Medical Centre, Ljubljana Slovenia. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is headquartered in West Perth, Australia.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharmaceutical Industry Clinical Trial Pharmaceutical Industry In China Health Sciences Clinical Research Dementia Alzheimer's Diseases Design Of Experiments Clinical Pharmacology

Is MXC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.0
52 Week Low 0.05
Average Volume 35,442
200-Day Moving Average 12.19
50-Day Moving Average 20.37
20-Day Moving Average 20.43
10-Day Moving Average 20.55
Average True Range 2.18
RSI (14) 54.13
ADX 44.98
+DI 11.00
-DI 2.86
Chandelier Exit (Long, 3 ATRs) 15.47
Chandelier Exit (Short, 3 ATRs) 25.53
Upper Bollinger Bands 22.05
Lower Bollinger Band 18.80
Percent B (%b) 0.68
BandWidth 15.87
MACD Line 0.19
MACD Signal Line -0.06
MACD Histogram 0.2494
Fundamentals Value
Market Cap 9.21 Million
Num Shares 43.9 Million
EPS -3.66
Price-to-Earnings (P/E) Ratio -5.74
Price-to-Sales 2.61
Price-to-Book 5.98
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.00
Resistance 3 (R3) 24.00 23.00 23.50
Resistance 2 (R2) 23.00 22.24 23.00 23.33
Resistance 1 (R1) 22.00 21.76 21.50 22.00 23.17
Pivot Point 21.00 21.00 20.75 21.00 21.00
Support 1 (S1) 20.00 20.24 19.50 20.00 18.83
Support 2 (S2) 19.00 19.76 19.00 18.67
Support 3 (S3) 18.00 19.00 18.50
Support 4 (S4) 18.00